Doxapram Hydrochloride Hydrate(CAS: 7081-53-0)

Doxapram Hydrochloride Hydrate is a crystalline compound with a molecular weight of approximately 271.7 g/mol. It has a solubility of about 32.5 g/L in water at 20°C. The compound is relatively stable under normal conditions but may undergo hydrolysis in the presence of water. It is slightly soluble in ethanol and almost insoluble in chloroform and ether.

Doxapram Hydrochloride Hydrate is typically synthesized by the reaction of 4-(2-hydroxy-5-oxopyridin-1(2H)-yl)butanoic acid with hydrochloric acid. The reaction is carried out in the presence of a catalyst such as sodium acetate, leading to a high yield of the desired product. The resulting product is then crystallized from a suitable solvent to obtain the hydrate form.

Doxapram Hydrochloride Hydrate is primarily used in the pharmaceutical industry as a respiratory stimulant. It is also used in the development of certain sensor technologies and in some polymer applications for its respiratory stimulant effects.

When handling Doxapram Hydrochloride Hydrate, it is important to use appropriate personal protective equipment (PPE) such as gloves, goggles, and a lab coat. Work should be conducted in a well-ventilated area or a fume hood. Spills should be cleaned up immediately using appropriate absorbent materials and disposing of waste properly. Safety data sheets (SDS) should be consulted for detailed handling and safety information.